2026³â 03¿ù 14ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

No Virus Transmission Detected at 300 Stores With Seoul Viosys UVC Air Purifying Sterilizer

Seoul Viosys to provide free UV sterilization technology license for the safety of public health
´º½ºÀÏÀÚ: 2022-03-21

ANSAN, SOUTH KOREA-- March 21, 2022 -- Seoul Viosys (KOSDAQ: 092190), a global optical semiconductor company, provided free air purifying sterilizers applied with Violeds, its UV LED sterilization solution technology, to more than 300 self-employed people suffering from COVID-19 pandemic. Later, when surveyed by phone, the beneficiaries said there was no outbreak of virus transmission at their stores, according to the Seoul Viosys announcement on the 17th.

Starting in 2020, Seoul Viosys conducted the ‘Violeds Sterilization Solution Campaign’ twice in its efforts for technological contribution. Seoul Viosys recruited participants from restaurants and government offices that accommodate more than 100 people and supplied its air sterilization module with Violeds technology to about 200 places for free, and none of the module-installed sites experienced virus transmission.

However, because each business site had different structures of the heating and cooling equipment, it was difficult to modify the product specification to achieve an optimal sterilization effect. Therefore, Seoul Viosys invested KRW 1 billion to develop an air purifying sterilizer with FDSYS, a local home appliance company, which can be used independently while increasing user convenience and sterilizing a large area in a short time.

In November 2021, Seoul Viosys carried out its 3rd technology contribution project for public safety and small business owners suffering from COVID-19. Participants were recruited through the website, and the final 300 owners through a lottery among 2,000 applicants were given the air purifying sterilizers for free of charge. In a survey of air purifying sterilizer users, 98% of those were willing to recommend the products, indicating high satisfaction among them.

“We have provided all licenses related to the air purifying sterilizers so that FDSYS can sell the Violeds solution with proven technology,” said Lee Young-joo, CEO of Seoul Viosys. “Seoul Viosys will continue to uphold the principle of No Competition with Our Customers.”

In an experiment with Korea University and an accredited research institute, Seoul Viosys confirmed that its sterilization technology sterilizes not only bacteria, but also 99% of delta variants and omicrons in only one second. The bio research team of Seoul Viosys continues its efforts to prove the excellence of the technology with its experimental results that the indoor infection rate can be lowered to around 1/30 with the air purifying sterilizer, which is equipped with Violeds technology.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Mobileum and NOHOLD Launch White-Labeled AI Assistant Offering for Telecom Enterprise Customers
GCT Semiconductor Partners with Skylo to Accelerate Global Satellite Connectivity
Micro LED Display Revenue to Double to $105 Million in 2026 Driven by Near-Eye Smart Watch and Public Display Applications
Sodali & Co Hires BlackRock Investment Stewardship AI and Data Lead
Energy Vault, Crusoe Sign Deal to Deploy Modular AI Factories for Crusoe Cloud
Belkin Introduces a New Accessory Collection for Samsung Galaxy S26 Series
U.S. Tech Company Coupang Named a 2026 LexisNexis Top 100 Global Innovator

 

SheltonAI Announces Global Expansion, Senior Leadership Appointments, ...
Kirin and Immunosens Begin Joint Development of Urinary IgA Self‑...
Positron AI Raises $230 Million Series B at Over $1 Billion Valuation ...
TRENDS Unifies 50+ Systems to Build AI-Ready Manufacturing Backbone
DCO Concludes 5th General Assembly with Adoption of the Kuwait Declara...
FDA Accepts NDA, Grants Priority Review for Takeda¡¯s Oveporexton (TAK...
Galderma Launches Restylane Defyne¢â and Refyne¢â OBT¢â Hyaluronic Aci...

 


°øÁö»çÇ×
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ÃÁö'
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬银öõ(ÜÄÒ¬ÜØ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..